Vandana Raman

Vandana Raman, MBBS, MD

Languages spoken: Sindhi, Urdu, English, Hindi, Marathi

Clinical Locations

Eccles Primary Children's Outpatient Services Building

801-213-3599

  • Dr. Raman is an Associate Professor in Pediatrics at the University of Utah. She is an Attending Physician in the Division of Pediatric Endocrinology, and provides care for children with diabetes and endocrine conditions in the inpatient and outpatient settings at Primary Children's and University hospitals and clinics .


    She is the Program director of Pediatric Endocrinology and Diabetes Fellowship Program at the University of Utah.


    She also serves as the Director of the DIME clinic (Diabetes Intensive management and education) and collaborates with behavioral health specialists to provide comprehensive care to patients with Type 1 diabetes.


    She is active in clinical research and is the primary investigator and co-investigator for a number of clinical trials including the Type 1 diabetes TrialNet study and has several national presentations and abstracts and publications in journals and textbook chapters.


    In addition to her clinical and research activities, she is actively involved in the training and mentoring of medical students, residents and fellows in pediatric medicine. She is a recipient of several teaching awards including the Gold Humanism and Excellence in Teaching award.

    She is active an active member of the Pediatric Endocrine Society in the Drug and Therapeutics and Education committees. She is board certified in Pediatric endocrinology She is passionate about treatment of patients with Type 1 diabetes. Her other clinical interests include disorders of growth, puberty, pituitary, adrenal and the thyroid as well as rare syndromes such as Russell-Silver syndrome and Turner’s syndrome.

    Specialties

    Board Certification

    American Board of Pediatrics (Sub: Pediatric Endocrinology)

  • Dr. Raman is an Associate Professor in Pediatrics at the University of Utah. She is an Attending Physician in the Division of Pediatric Endocrinology, and provides care for children with diabetes and endocrine conditions in the inpatient and outpatient settings at Primary Children's and University hospitals and clinics .


    She is the Program director of Pediatric Endocrinology and Diabetes Fellowship Program at the University of Utah.


    She also serves as the Director of the DIME clinic (Diabetes Intensive management and education) and collaborates with behavioral health specialists to provide comprehensive care to patients with Type 1 diabetes.


    She is active in clinical research and is the primary investigator and co-investigator for a number of clinical trials including the Type 1 diabetes TrialNet study and has several national presentations and abstracts and publications in journals and textbook chapters.


    In addition to her clinical and research activities, she is actively involved in the training and mentoring of medical students, residents and fellows in pediatric medicine. She is a recipient of several teaching awards including the Gold Humanism and Excellence in Teaching award.

    She is active an active member of the Pediatric Endocrine Society in the Drug and Therapeutics and Education committees. She is board certified in Pediatric endocrinology She is passionate about treatment of patients with Type 1 diabetes. Her other clinical interests include disorders of growth, puberty, pituitary, adrenal and the thyroid as well as rare syndromes such as Russell-Silver syndrome and Turner’s syndrome.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Board Certification
    American Board of Pediatrics (Sub: Pediatric Endocrinology)

    Education history

    Fellowship Pediatric Endocrinology - Baylor College of Medicine, Texas Children's Hospital Fellow
    Pediatrics - Western Michigan University Homer Stryker M.D. School of Medicine, Bronson Children's Hospital Resident
    Professional Medical Medicine - University of Mumbai, Dr. D.Y. Patil Medical College M.B.B.S.
    University of Mumbai, K.J. College of Arts & Sciences Higher Secondary Certificate

    Selected Publications

    Journal Article

    1. Libman I, Bingley PJ, Becker D, Buckner JH, DiMeglio LA, Gitelman SE, Greenbaum C, Haller MJ, Ismail HM, Krischer J, Moore WV, Moran A, Muir AB, Raman V, Steck AK, Toledo FGS, Wentworth J, Wherrett D, White P, You L, Herold KC, Type 1 Diabetes TrialNet Study Group (2023). Hydroxychloroquine in Stage 1 Type 1 Diabetes. Diabetes Care, 46(11), 2035-2043.
    2. Mistry S, Gouripeddi R, Raman V, Facelli JC (2023). Sequential data mining of infection patterns as predictors for onset of type 1 diabetes in genetically at-risk individuals. J Biomed Inform, 142, 104385.
    3. Raleigh ZT, Drapkin ZA, Al-Hamad DM, Mutyala K, Masih JR, Raman VS (2022). Outcomes of children with severe diabetic ketoacidosis managed outside of a pediatric intensive care unit. J Pediatr Endocrinol Metab.
    4. Mistry S, Gouripeddi R, Raman V, Facelli JC (2022). Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering. Diabetologia.
    5. Lahoti A, Yu C, Brar PC, Dalgo A, Gourgari E, Harris R, Kamboj MK, Marks S, Nandagopal R, Page L, Raman V, Reynolds DG, Sarafoglou K, Terrell C, Stanley TL (2021). An endocrine perspective on menstrual suppression for adolescents: achieving good suppression while optimizing bone health. J Pediatr Endocrinol Metab.
    6. Ashraf AP, Sunil B, Bamba V, Breidbart E, Brar PC, Chung S, Gupta A, Khokhar A, Kumar S, Lightbourne M, Kamboj MK, Miller RS, Patni N, Raman V, Shah AS, Wilson DP, Kohn B (2021). Case Studies in Pediatric Lipid Disorders and Their Management. J Clin Endocrinol Metab.
    7. Miller R, Ashraf AP, Gourgari E, Gupta A, Kamboj MK, Kohn B, Lahoti A, Mak D, Mehta S, Mitchell D, Patel N, Raman V, Reynolds DG, Yu C, Krishnan S (2021). SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations. Endocrinol Diabetes Metab, 4(3), e00262.
    8. Raman V, Foster CM (2020). Metformin Treatment of Pediatric Obesity. Pediatrics, 147(3).
    9. Burrage LC, Reynolds JJ, Baratang NV, Phillips JB, Wegner J, McFarquhar A, Higgs MR, Christiansen AE, Lanza DG, Seavitt JR, Jain M, Li X, Parry DA, Raman V, Chitayat D, Chinn IK, Bertuch AA, Karaviti L, Schlesinger AE, Earl D, Bamshad M, Savarirayan R, Doddapaneni H, Muzny D, Jhangiani SN, Eng CM, Gibbs RA, Bi W, Emrick L, Rosenfeld JA, Postlethwait J, Westerfield M, Dickinson ME, Beaudet AL, Ranza E, Huber C, Cormier-Daire V, Shen W, Mao R, Heaney JD, Orange JS, University of Washington Center for Mendelian Genomics, Undiagnosed Diseases Network, Bertola D, Yamamoto GL, Baratela WAR, Butler MG, Ali A, Adeli M, Cohn DH, Krakow D, Jackson AP, Lees M, Offiah AC, Carlston CM, Carey JC, Stewart GS, Bacino CA, Campeau PM, Lee B (2019). Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes. Am J Hum Genet, 104(3), 422-438.
    10. Al-Hamad D, Raman V (10/2017). Metabolic Syndrome in children and adolescents. 6(4), 397-107.
    11. Blackman SM, Raghinaru D, Adi S, Simmons JH, Ebner-Lyon L, Chase HP, Tamborlane WV, Schatz DA, Block JM, Litton JC, Raman V, Foster NC, Kollman CR, DuBose SN, Miller KM, Beck RW, DiMeglio LA (2014). Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes, 15(8), 564-72.
    12. Yazdani P, Raman V, Haymond M (2012). A single sample GnRHa stimulation test in the diagnosis of precocious puberty. Int J Pediatr Endocrinol, 2012(1), 23.
    13. Raman VS, Loar RW, Renukuntla VS, Hassan KV, Fishman DS, Gilger MA, Heptulla RA (2011). Hyperglycemia and diabetes mellitus in children with pancreatitis. J Pediatr, 158(4), 612-616.e1.
    14. Raman VS, Mason KJ, Rodriguez LM, Hassan K, Yu X, Bomgaars L, Heptulla RA (2010). The role of adjunctive exenatide therapy in pediatric type 1 diabetes. Diabetes Care, 33(6), 1294-6.
    15. Raman VS, Heptulla RA (2009). New potential adjuncts to treatment of children with type 1 diabetes mellitus. Pediatr Res, 65(4), 370-4.
    16. Raman VS, Heptulla RA (2009). Hyperlipidemia in children. Tex Med, 105(2), 38-43.
    17. Patel DR, Shivdasani V, Baker RJ (2005). Management of sport-related concussion in young athletes. Sports Med, 35(8), 671-84.

    Review

    1. Raman V, Gupta A, Ashraf AP, Breidbart E, Gourgari E, Kamboj M, Kohn B, Krishnan S, Lahoti A, Matlock K, Mehta S, Mistry S, Miller R, Page L, Reynolds D, Han JC (2022). Pharmacologic Weight Management in the Era of Adolescent Obesity. [Review]. J Clin Endocrinol Metab, 107(10), 2716-2728.

    Book Chapter

    1. Raman V, Kamboj M (2019). Endocrine Concerns in Obesity, Chronic Illness and Disability. In Marisha Agana, Donald E. Greydanus, Manmohan K. Kamboj, Joav Merrick (Eds.), Chronic Illness and Disability. Nova Publishers.
    2. Raman V (2016). Klinefelter Syndrome. In Rubin I.L., Merrick J., Greydanus D.E (Eds.), Health Care for People with Intellectual and Developmental Disabilities across the Lifespan. Springer Publishing.
    3. Alonso G, Hicks K, Raman V, Constantacos C, Ham JY, Haymond M, Yazdani P in Lowry AW, Nag PK, Bhata KY, eds (01/01/2011). Endocrinology. In Texas Children's Hospital Handbook of Pediatrics and Neonatology. New York, NY: McGraw-Hill Professional, Inc.

    Abstract

    1. Turner S, Giles L, Caplin D, Murray M, Dwyer L, Raman V (2021). Personalized multidisciplinary therapy and Intensive Diabetes Management in Adolescents with Poorly Controlled Type 1 Diabetes [Abstract].
    2. Al-Reyess H, Lahoti M, Kamboj M, Raman V, Sarafoglu K (2021). Manipulating hydrocortisone tablets and other practices to achieve small incremental glucocorticoid dosing in the treatment of infants and young children with CAH <10 years of age: A nationwide survey. [Abstract].
    3. Meder M, Raman V, Smego A, Murray M, Foster M, Kocolas I, Al-Hamad D (2021). Infantile hypophosphatasia as a cause of severe hypotonia and hypercalcemia [Abstract].
    4. Jelley H, Raman V, Murray M, Barnhart D, Al-Hamad D (2020). .Jelley H, Raman V, Al-Hamad D (2020)  Insulinomas Presenting with Primary Neuropsychiatric Symptoms: A Case Series. [Abstract]. 93(suppl 1), 35.
    5. Zarse A, Murray M, Karmazin A, Timme K, Peterson D, Tower D, Raman V (2020). Subcutaneous fat necrosis in a newborn associated with severe hypercalcemia and nephrocalcinosis [Abstract]. 93(suppl 1), 35.
    6. Raleigh Z, Al-Hamad D, Murray M, Raman V (2019). Management of Severe Diabetic Ketoacidosis Outside of the Pediatric Intensive Care Unit [Abstract].
    7. Al-Hamad D, Murray M, Clements S, Raman V (2017). A rare case of insulinoma in an adolescent with recurrent episodes of altered mental status [Abstract].

    Newspaper

    1. Raman V, Kamboj MK (2006). Thyroiditis in adolescents. American Academy of Pediatrics Section on Adolescent Health Newsletter, pp. 18-20.

    Other

    1. Al-Hamad D, Raman V, Lahoti A (2021). Zegalogue PES Drug and Therapeutics Update. Pediatric Endocrine Society Newsletter.
    2. Raman V, Ryabets A (2021). Thyquidity PES Drug and Therapeutics Update . Pediatric Endocrine Society Newsletter.
    3. Raman V, Mehta S, Lahoti A (2020).  Liragutide PES Drug and Therapeutics Update. Pediatric Endocrine Society Newsletter.
    4. Raman V, Yu C (2019). Baqsimi and Gvoke PES Drug and Therapeutics Update  . Pediatric Endocrine Society Newsletter.

    Video/Film/CD/Web/Podcast

    1. Raman V, Norlin C (2018). Turner Syndrome [Web]. Available: ut.medicalhomeportal.org/diagnoses-and-conditions/turner-syndrome..
    2. Jolma K, Raman V, Norlin C (2011). Turner Syndrome [Web]. Available: ut.medicalhomeportal.org/diagnoses-and-conditions/turner-syndrome..